Subscribe to RSS
DOI: 10.3233/PIC-14112
Adjunctive and novel therapies for sepsis
Subject Editor:
Publication History
09 October 2014
29 October 2014
Publication Date:
28 July 2015 (online)

Abstract
Primary goals of sepsis therapy include early, appropriate antimicrobial therapy and prompt recognition and reversal of shock. Despite these measures, however, sepsis remains an important source of pediatric morbidity and mortality. Here we review rationale and existing evidence in support of adjunctive sepsis therapies including extracorporeal support, immunomodulation, and mitochondria-targeted therapies. While each of these therapeutic modalities shows promise, additional studies are urgently needed to identify the right patients, the right timing, and the right context for these interventions.